Transfection Reagent for Calu-6 Cells (Lung Carcinoma Cell, HTB-56)

Altogen Biosystems is an international developer and laboratory for genetic research. Laboratory offers and additional experiments include IC-50 assays, toxicology assays, 28-day generation of stably-transfected cells, RNAi testing and more. Dedicated to aiding pharmaceutical companies with cutting-edge and specialized services, Altogen Biosystems ventures to optimize modern laboratory discoveries. Visit the catalog of xenograft models for a Calu-6 xenograft model .

Lung cancer has posed a particular challenge to medical researchers; though there are patients that can serve as test subjects during clinical trials, such trials take months, if not years to complete. Such issues have been resolved through the advent of cell lines that accurately replicate those that would be found in tumors, and can react appropriately to introduced drugs and nucleic acid sequences. With the right transfection reagents , research investigating the role that genetic mechanisms play in cell proliferation can give accurate data that translates into valuable preclinical information. Calu-6 cells, which are epithelial lung cancer cells, were derived from human tissue, and are known for having been used to gauge the interaction between antimycin A and lung cancer, giving the medical field information regarding the effects of reactive oxygen species on cell apoptosis.